168 related articles for article (PubMed ID: 2222011)
1. Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma.
van Heerden JA; Grant CS; Gharib H; Hay ID; Ilstrup DM
Ann Surg; 1990 Oct; 212(4):395-400; discussion 400-1. PubMed ID: 2222011
[TBL] [Abstract][Full Text] [Related]
2. DNA analysis and persistent hypercalcitoninemia in medullary thyroid carcinoma.
Jeng TK; Lee CH; Wang HC; Chiu JW; Lui WY
Zhonghua Yi Xue Za Zhi (Taipei); 1993 May; 51(5):340-4. PubMed ID: 8334560
[TBL] [Abstract][Full Text] [Related]
3. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
[TBL] [Abstract][Full Text] [Related]
4. Medullary carcinoma of the thyroid gland and the MEN 2 syndromes.
Skinner MA; Wells SA
Semin Pediatr Surg; 1997 Aug; 6(3):134-40. PubMed ID: 9263335
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of reoperations for medullary thyroid carcinoma.
Fialkowski E; DeBenedetti M; Moley J
World J Surg; 2008 May; 32(5):754-65. PubMed ID: 18188643
[TBL] [Abstract][Full Text] [Related]
6. Surgical treatment of medullary carcinoma of the thyroid.
Block MA
Otolaryngol Clin North Am; 1990 Jun; 23(3):453-73. PubMed ID: 1973281
[TBL] [Abstract][Full Text] [Related]
7. Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B.
O'Riordain DS; O'Brien T; Weaver AL; Gharib H; Hay ID; Grant CS; van Heerden JA
Surgery; 1994 Dec; 116(6):1017-23. PubMed ID: 7985081
[TBL] [Abstract][Full Text] [Related]
8. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
[TBL] [Abstract][Full Text] [Related]
9. Surgical treatment of medullary thyroid carcinoma in a thirteen-year-old girl with MEN 2B.
Tisell LE; Jansson S
Henry Ford Hosp Med J; 1989; 37(3-4):157-9. PubMed ID: 2576953
[TBL] [Abstract][Full Text] [Related]
10. Should patients with medullary thyroid carcinoma undergo extensive lymph node (re)operation to improve long-term survival?
Brumsen C; Haak HR; Goslings BM; van de Velde CJ
Henry Ford Hosp Med J; 1992; 40(3-4):271-5. PubMed ID: 1483874
[TBL] [Abstract][Full Text] [Related]
11. Familial nonmultiple endocrine neoplasia medullary thyroid carcinoma: an evolving clinical entity.
McHenry CR; Oppenheim DS; Murphy T; Broughan T; Vogt D; Goldfarb WB
Surgery; 1992 Oct; 112(4):728-32; discussion 732-3. PubMed ID: 1411944
[TBL] [Abstract][Full Text] [Related]
12. Biochemical results of reoperations for medullary thyroid carcinoma.
Fernandez Vila JM; Peix JL; Mandry AC; Mezzadri NA; Lifante JC
Laryngoscope; 2007 May; 117(5):886-9. PubMed ID: 17473689
[TBL] [Abstract][Full Text] [Related]
13. [Reintervention in C-cell carcinoma].
Wahl RA; Goretzki PE; Branscheid D; Vietmeier P; Röher HD
Wien Klin Wochenschr; 1988 May; 100(11):348-51. PubMed ID: 2900580
[TBL] [Abstract][Full Text] [Related]
14. Medullary carcinoma of the thyroid gland.
Chong GC; Beahrs OH; Sizemore GW; Woolner LH
Cancer; 1975 Mar; 35(3):695-704. PubMed ID: 1111937
[TBL] [Abstract][Full Text] [Related]
15. Medullary thyroid carcinoma: genetic advances, treatment recommendations, and the approach to the patient with persistent hypercalcitoninemia.
Chi DD; Moley JF
Surg Oncol Clin N Am; 1998 Oct; 7(4):681-706. PubMed ID: 9735129
[TBL] [Abstract][Full Text] [Related]
16. Long-term prognosis of medullary thyroid carcinoma.
Rendl G; Manzl M; Hitzl W; Sungler P; Pirich C
Clin Endocrinol (Oxf); 2008 Sep; 69(3):497-505. PubMed ID: 18331612
[TBL] [Abstract][Full Text] [Related]
17. [The prognostic importance of calcitonin screening in familial medullary thyroid carcinoma].
Raue F; Geiger S; Buhr H; Frank-Raue K; Ziegler R
Dtsch Med Wochenschr; 1993 Jan; 118(3):49-52. PubMed ID: 8425457
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes of patients with hypercalcitoninemia after initial treatment for medullary thyroid cancer and postoperative serum calcitonin cutoffs for predicting structural recurrence.
Cho YY; Jang HW; Jang JY; Kim TH; Choe JH; Kim JH; Kim JS; Kim SW; Chung JH
Head Neck; 2016 Oct; 38(10):1501-8. PubMed ID: 27062421
[TBL] [Abstract][Full Text] [Related]
19. [Early therapeutic management of patients genetically predisposed to medullary thyroid cancer].
Murat A; Modigliani E; Conte-Devolx B; Rohmer V; Leclerc L; Guilhem I; Bigorgne JC; Boneu A; Maes B; Chabre O; Niccoli P; Schuffenecker I; Giraud S
Ann Chir; 1998; 52(5):455-60. PubMed ID: 9752487
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of calcitonin immunoreactivity, amyloid staining, and flow cytometric DNA measurements in medullary thyroid carcinoma.
Pyke CM; Hay ID; Goellner JR; Bergstralh EJ; van Heerden JA; Grant CS
Surgery; 1991 Dec; 110(6):964-70; discussion 970-1. PubMed ID: 1745984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
